US 12144864
Tubulysins and protein-tubulysin conjugates
granted A61KA61K31/454A61K47/545
Quick answer
US patent 12144864 (Tubulysins and protein-tubulysin conjugates) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/454, A61K47/545, A61K47/65, A61K47/6803